Audrey Kunin, Chief Product Officer at NovaBay Pharmaceuticals, Inc. (NBY), bought 91,133 shares at $0.46 ($42K) on 2021-11-22, disclosed to the SEC on 2021-11-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.46 | 25,000 | $12K | 27.4% |
| 2 | $0.46 | 66,133 | $30K | 72.6% |
| Total | $0.46 avg | 91,133 | $42K | 100% |
| Filing → |
| NBY | SELL | 2022-09-16 | $47K | — | Filing → |
| NBY | BUY | 2021-12-07 | $47K | — | Filing → |
| NBY | BUY | 2021-12-06 | $252K | — | Filing → |